NewsLetter: Revolutionizing Blood Tests + Covid-19 Tracking and Testing
OurCrowd
AUGUST 10, 2020
OurCrowd portfolio company Sight Diagnostics raised $71M for Its OLO Blood Analyzer with participation from Koch Disruptive Technologies, Longliv Ventures and OurCrowd. Webinar Aug.12: $71M Round for Sight Diagnostics. The company is researching the detection of new diseases and blood factors affecting the severity of Covid-19.
Let's personalize your content